MPG.eBooks - Search Results

Cover Image

181

Per oral endoscopic myotomy for esophageal motility disorders : a review of clinical, cost-effectiveness, and guidelines

by Peprah, Kwakye, Adcock, Lorna
Published 2018

CADTH

Cover Image

182

Ixekizumab (Taltz)

Published 2017

CADTH

Cover Image

183

Clonidine for the treatment of psychiatric conditions and symptoms : a review of clinical effectiveness, safety, and guidelines

by Chiu, Stephanie, Campbell, Kaitryn
Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

184

Airway pressure release ventilation for acute respiratory distress syndrome : clinical effectiveness and guidelines

by Seal, Kelsey
Published 2018

CADTH

Cover Image

185

Off-label use of intravenous immunoglobulin for dermatological conditions : a review of clinical effectiveness

by Ho, Chuong, Visintini, Sarah
Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

186

Occupational therapy for chronic pain management using the biopsychosocial approach : a review of the clinical and cost-effectiveness and guidelines

by Ho, Chuong, Argáez, Charlene
Published 2017

CADTH

Cover Image

187

Cyclosporine for moderate to severe plaque psoriasis in adults : a review of clinical effectiveness and safety

by Singh, Kavita, Argáez, Charlene
Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

188

Intravesical botulinum toxin for adults with non-neurogenic bladder conditions : a review of clinical effectiveness, cost-effectiveness and guidelines

by Ho, Chuong, Visintini, Sarah
Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

189

Bowel preparation for colorectal procedures : a review of clinical effectiveness, cost-effectiveness and guidelines

by La Fleur, Philip, Adcock, Lorna
Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

190

Chest x-rays around placement in long-term care facilities : a review of clinical utility and guidelines

by Pohar, Ron, Adcock, Lorna
Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

191

CADTH Canadian Drug Expert Committee recommendation: Migalastat (Galafold -- Amicus therapeutics) : indication : Fabry disease

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

192

CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

193

CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

194

Omalizumab (Xolair)

Published 2017

CADTH

Cover Image

195

CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier Canada Inc.) : indication: heart failure, NYHA class II to III.

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

196

Patient group input submissions: Ixekizumab (Taltz) for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or photothe...

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

197

Patient group input submissions: Omalizumab (Xolair) for asthma, severe persistent

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

198

Patient group input submissions: Sapropterin dihydrochloride (Kuvan) for phenylketonuria (PKU)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

199

Viscosupplementation for knee osteoarthritis : a review of clinical and cost-effectiveness and guidelines

by Kaulback, Kellee, Jones, Sarah, Wells, Charlotte, Felipe, Eldiflor
Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

200

CADTH Canadian Drug Expert Committee final recommendation: Sapropterin -- resubmission (Kuvan -- BioMarin Pharmaceuticals Canada Inc.) : indication: to reduce blood phenylalanine l...

Published 2016

Canadian Agency for Drugs and Technologies in Health

5
6
7
8
9
10
11
12
13
14
15